ZACCARDELLI DAVID bought SABS
January 5, 2026 · Form 4 insider transaction
ZACCARDELLI DAVID bought 240,000 shares of SAB Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
240,000
Price
$0.00
Total value
N/A
InsiderZACCARDELLI DAVID
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after240,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the inaugural grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in three equal annual installments on January 5, 2027, January 5, 2028 and January 5, 2029.; This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.